Previous close | 1.6050 |
Open | 1.6130 |
Bid | 1.5790 x N/A |
Ask | 1.6160 x N/A |
Day's range | 1.5980 - 1.6270 |
52-week range | 1.1355 - 2.7680 |
Volume | |
Avg. volume | 15 |
Market cap | N/A |
Beta (5Y monthly) | N/A |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | 31 Jul 2024 - 05 Aug 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
CONCORD, Calif., June 21, 2024--Cerus Corporation (Nasdaq:CERS) today announced a lunch symposium and selection of abstracts at the 38th International Congress of the International Society of Blood Transfusion (ISBT), taking place in Barcelona, Spain, from June 23 through June 27. Transfusion medicine experts and professionals from around the world attend the ISBT Congress.
If you are building a properly diversified stock portfolio, the chances are some of your picks will perform badly. But...
CONCORD, Calif., June 14, 2024--Cerus Corporation (Nasdaq: CERS) is proud to announce its celebration of World Blood Donor Day 2024.